Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Acetone Metabolism in Humans During Diabetic Ketoacidosis

View through CrossRef
Plasma acetone turnover rates were measured with the primed continuous infusion of 2-[14C]acetone in patients with moderate to severe diabetic ketoacidosis. Plasma acetone turnover rates ranged from 1.52 to 15.9 μmol · kg−1 · min−1 (108–1038 n,mol · 1.73 m−2 min−1) and were directly related to the plasma acetone concentrations that ranged from 0.47 to 7.61 mM. The average acetoneturnover rate was 6.45 μmol kg−1 min−1 (533 μmol · 1.73 m−2 min−1), a value twice that obtained in a similar group of diabetic ketoacidotic patients via the single-injection technique of 2-[14C]acetone administration. Degradation of urine glucose revealed that 14C from administered 2-[14C]acetone was principally located in carbons 1, 2, 5, and 6 of the glucose molecule in five of six patients. This distribution is similar to that expected from 2-[14C]pyruvate, suggesting that acetone was converted to glucose through pyruvate. In one patient, label was located predominantly in glucose carbons 3 and 4, indicating that acetone metabolism maybe different in some patients. Acetol (1-hydroxyacetone) and 1,2-propanediol (PPD), two possible metabolites of acetone, were detected in plasma of the patients. The concentrations of Acetol ranged from 0 to 0.48 mM and of PPD ranged from 0 to 0.53 mM. The concentrations of each metabolite were directly related to the plasma acetone concentrations. During the continuous infusion of 2-[14C]acetone, the specific activities of plasma glucose and PPD rose continuously but did not reach constant values. Estimates of theminimal percent plasma glucose and PPD derived from plasma acetone averaged 2.1 and 74%, respectively.
Title: Acetone Metabolism in Humans During Diabetic Ketoacidosis
Description:
Plasma acetone turnover rates were measured with the primed continuous infusion of 2-[14C]acetone in patients with moderate to severe diabetic ketoacidosis.
Plasma acetone turnover rates ranged from 1.
52 to 15.
9 μmol · kg−1 · min−1 (108–1038 n,mol · 1.
73 m−2 min−1) and were directly related to the plasma acetone concentrations that ranged from 0.
47 to 7.
61 mM.
The average acetoneturnover rate was 6.
45 μmol kg−1 min−1 (533 μmol · 1.
73 m−2 min−1), a value twice that obtained in a similar group of diabetic ketoacidotic patients via the single-injection technique of 2-[14C]acetone administration.
Degradation of urine glucose revealed that 14C from administered 2-[14C]acetone was principally located in carbons 1, 2, 5, and 6 of the glucose molecule in five of six patients.
This distribution is similar to that expected from 2-[14C]pyruvate, suggesting that acetone was converted to glucose through pyruvate.
In one patient, label was located predominantly in glucose carbons 3 and 4, indicating that acetone metabolism maybe different in some patients.
Acetol (1-hydroxyacetone) and 1,2-propanediol (PPD), two possible metabolites of acetone, were detected in plasma of the patients.
The concentrations of Acetol ranged from 0 to 0.
48 mM and of PPD ranged from 0 to 0.
53 mM.
The concentrations of each metabolite were directly related to the plasma acetone concentrations.
During the continuous infusion of 2-[14C]acetone, the specific activities of plasma glucose and PPD rose continuously but did not reach constant values.
Estimates of theminimal percent plasma glucose and PPD derived from plasma acetone averaged 2.
1 and 74%, respectively.

Related Results

Acetone Metabolism During Diabetic Ketoacidosis
Acetone Metabolism During Diabetic Ketoacidosis
The presence and the importance of acetone and its metabolism in diabetic ketoacidosis has largely been ignored. Therefore, we studied acetone metabolism in nine diabetic patients ...
Mortality and its predictors in Adult Diabetic ketoacidosis patients in East Africa: A 2025 Systematic review and meta-analysis
Mortality and its predictors in Adult Diabetic ketoacidosis patients in East Africa: A 2025 Systematic review and meta-analysis
Background Diabetes ketoacidosis occurs at an estimated rate between 4.6 and 8 episodes per 100 patient-years in individuals with diabetes. Up to 47% of diabetes-related ketoacidos...
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalization. Sodium-gluco...
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Abstract On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalizat...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Introduction: Ketoacidosis is a rare but serious side effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i), possibly overlooked in clinical practice. We aim to further char...
FREQUENCY OF FACTORS LEADING TO DEVELOPING OF DIABETES KETOACIDOSIS IN PATIENTS WITH TYPE 1 DIABATES
FREQUENCY OF FACTORS LEADING TO DEVELOPING OF DIABETES KETOACIDOSIS IN PATIENTS WITH TYPE 1 DIABATES
Background: Diabetic ketoacidosis (DKA) is a serious, acute complication of type 1 diabetes mellitus, characterized by hyperglycemia, metabolic acidosis, and ketonemia. Despite adv...

Back to Top